Trial Profile
Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2021
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Nicotine replacement therapy (Primary)
- Indications Alcoholism; Smoking withdrawal
- Focus Therapeutic Use
- 30 Mar 2020 Status changed from active, no longer recruiting to completed.
- 15 Aug 2019 Planned End Date changed from 1 Feb 2021 to 1 Feb 2020.
- 15 Aug 2019 Planned primary completion date changed from 1 Nov 2020 to 1 Feb 2020.